Last Action hero
Think you may have bought a turkey?
20-fold growth since the height of the pandemic
Market conditions are reminiscent of the soft landing that followed Alan Greenspan’s ‘Fed pivot’
Magnificent Seven tech stocks have come off the boil but is it just a blip?
Does size matter any more? FT Alphaville examines the ‘death of small-caps’ narrative
Small-cap premium can disappear after periods of strong performance, pulling down long-term average
Reflation Britannia
Executives and governments must invest in growth
Which of these is driving the market? Yes.
US equities, led by ‘Magnificent Seven’, now account for more than 70% of global developed markets
But the boost to liquidity can prove shortlived
Uncertain executives are favouring share buybacks over tapping buoyant markets to fund investment
Broader rally, concentrated earnings
For a biotech with a tiny free float, shrinking revenues and mounting losses, liquidity might not be the big issue
And momentum vs sentiment
As bidders circle undervalued London-listed companies, are there really bargains for private investors?
Unusually big performance gap opens up as investors drive up big tech stocks while interest rates hurt smaller companies
Shares of company behind former president’s Truth Social platform rise 16% in first day of trading
A bargain in the aggregate, not the particular
After years of underperformance, some investors eye bargains on London market
We don’t have the conditions to support a sustained US equity bull run
Hotel groups and carmakers outperform Stoxx Europe 600 as recession fears recede
‘No one is really worried about small downturns,’ say investors
Shares have risen 65 per cent in the past year
International Edition